Corvus Pharmaceuticals, Inc (CRVS) insider trading

Every open-market stock purchase and sale by Corvus Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $334K over the last 12 months (2 buys).
  • Last insider buy: David Scott Moore (Insider), $250K, 4 months ago.

Last 12 months: insiders bought $334K (2 buys) and sold $0 (0 sales). Last close $11.12 on Jun 4, 2026.

Recent CRVS insider trades

DateInsiderTradeValue
Jun 11, 2026David Scott Moore (Insider)Bought$250K
Jun 11, 2026Linda Grais (Insider)Bought (not open market)—
Jun 11, 2026David Scott Moore (Insider)Bought (not open market)—
Jun 11, 2026Peter A. Thompson (Insider)Bought (not open market)—
Jun 11, 2026Richard van den Broek (Insider)Bought (not open market)—
Jun 11, 2026Ian T Clark (Insider)Bought (not open market)—
May 18, 2026Richard A Miller Md (CEO)Bought$60.3K
May 18, 2026Richard A Miller Md (CEO)Bought$23.2K
Apr 23, 2026Andrew C. Chan (Insider)Bought (not open market)—
Jan 28, 2026Peter A. Thompson (10% owner)Bought (not open market)—
Jan 28, 2026Peter A. Thompson (10% owner)Bought (not open market)—
Dec 4, 2025Richard A Miller Md (CEO)Bought (not open market)—
Dec 4, 2025Jeffrey Arcara (C-suite exec)Bought (not open market)—
Dec 4, 2025Leiv Lea (CFO)Bought (not open market)—
Dec 4, 2025William Benton Jones (Insider)Bought (not open market)—
Oct 2, 2025David Scott Moore (Insider)Bought (not open market)—

Who's trading CRVS

Get free alerts when an insider at Corvus Pharmaceuticals, Inc files a new trade →